Supreme Court declines to hear challenges to Medicare drug price negotiations

The U.S. Supreme Court has declined to hear appeals from pharmaceutical companies seeking to block the federal government from negotiating prices for certain prescription drugs under Medicare. This decision leaves in place lower court rulings that allow the government's price-setting program to proceed.

We have not fully decoded this article yet, so read the full story at WPLG Local 10.